Duncker Streett & Co’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12K | Hold |
63
| – | – | ﹤0.01% | 414 |
|
|
2026
Q1 | $10.6K | Hold |
63
| – | – | ﹤0.01% | 425 |
|
|
2025
Q4 | $10.6K | Hold |
63
| – | – | ﹤0.01% | 414 |
|
|
2025
Q3 | $9.1K | Hold |
63
| – | – | ﹤0.01% | 437 |
|
|
2025
Q2 | $7.97K | Sell |
63
-14
| -18% | -$1.72K | ﹤0.01% | 440 |
|
|
2025
Q1 | $9.85K | Hold |
77
| – | – | ﹤0.01% | 415 |
|
|
2024
Q4 | $10.2K | Sell |
77
-6
| -7% | -$843 | ﹤0.01% | 440 |
|
|
2024
Q3 | $12.1K | Hold |
83
| – | – | ﹤0.01% | 404 |
|
|
2024
Q2 | $11.4K | Sell |
83
-45
| -35% | -$6.01K | ﹤0.01% | 407 |
|
|
2024
Q1 | $17.6K | Sell |
128
-85
| -40% | -$11.6K | ﹤0.01% | 382 |
|
|
2023
Q4 | $28.9K | Sell |
213
-121
| -36% | -$14.8K | 0.01% | 344 |
|
|
2023
Q3 | $40.8K | Hold |
334
| – | – | 0.01% | 319 |
|
|
2023
Q2 | $42.4K | Hold |
334
| – | – | 0.01% | 312 |
|
|
2023
Q1 | $43.1K | Hold |
334
| – | – | 0.01% | 306 |
|
|
2022
Q4 | $43.9K | Sell |
334
-210
| -39% | -$27.1K | 0.01% | 309 |
|
|
2022
Q3 | $64K | Hold |
544
| – | – | 0.02% | 284 |
|
|
2022
Q2 | $64K | Hold |
544
| – | – | 0.02% | 291 |
|
|
2022
Q1 | $71K | Sell |
544
-657
| -55% | -$85.6K | 0.01% | 297 |
|
|
2021
Q4 | $183K | Sell |
1,201
-156
| -11% | -$24.2K | 0.03% | 250 |
|
|
2021
Q3 | $219K | Hold |
1,357
| – | – | 0.04% | 227 |
|
|
2021
Q2 | $222K | Buy |
1,357
+35
| +3% | +$5.39K | 0.04% | 227 |
|
|
2021
Q1 | $199K | Sell |
1,322
-600
| -31% | -$95.3K | 0.04% | 231 |
|
|
2020
Q4 | $291K | Sell |
1,922
-91
| -5% | -$13K | 0.06% | 202 |
|
|
2020
Q3 | $273K | Sell |
2,013
-65
| -3% | -$8.82K | 0.06% | 206 |
|
|
2020
Q2 | $284K | Hold |
2,078
| – | – | 0.07% | 199 |
|
|
2020
Q1 | $224K | Sell |
2,078
-125
| -6% | -$14.4K | 0.06% | 223 |
|
|
2019
Q4 | $265K | Hold |
2,203
| – | – | 0.06% | 231 |
|
|
2019
Q3 | $219K | Hold |
2,203
| – | – | 0.05% | 244 |
|
|
2019
Q2 | $240K | Hold |
2,203
| – | – | 0.05% | 239 |
|
|
2019
Q1 | $246K | Hold |
2,203
| – | – | 0.06% | 241 |
|
|
2018
Q4 | $212K | Hold |
2,203
| – | – | 0.06% | 239 |
|
|
2018
Q3 | $269K | Hold |
2,203
| – | – | 0.06% | 243 |
|
|
2018
Q2 | $242K | Buy |
2,203
+150
| +7% | +$16K | 0.06% | 242 |
|
|
2018
Q1 | $219K | Buy |
2,053
+405
| +25% | +$44.9K | 0.06% | 247 |
|
|
2017
Q4 | $176K | Buy |
1,648
+361
| +28% | +$38.6K | 0.05% | 267 |
|
|
2017
Q3 | $143K | Buy |
1,287
+432
| +51% | +$46.2K | 0.04% | 272 |
|
|
2017
Q2 | $88K | Hold |
855
| – | – | 0.03% | 331 |
|
|
2017
Q1 | $84K | Buy |
855
+255
| +43% | +$24.4K | 0.03% | 343 |
|
|
2016
Q4 | $53K | Hold |
600
| – | – | 0.02% | 382 |
|
|
2016
Q3 | $58K | Buy |
+600
| New | +$57.1K | 0.02% | 349 |
|
|
2016
Q1 | – | Sell |
-450
| Closed | -$51K | – | 627 |
|
|
2015
Q4 | $51K | Buy |
+450
| New | +$48.8K | 0.02% | 359 |
|
Other funds holding IBB
CB
Duncker Streett & Co's IBB Position: Q2 2026 in Review
Duncker Streett & Co held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 63 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #414.
Duncker Streett & Co first reported a position in IBB in Q4 2015 and has held it in 41 quarters since. The position peaked at $291K in Q4 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Duncker Streett & Co held 63 shares of iShares Biotechnology ETF worth $12K as of Q2 2026.
- Duncker Streett & Co left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up ﹤0.01% of Duncker Streett & Co's portfolio in Q2 2026, its #414 holding.
- Duncker Streett & Co first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 41 quarters since.
- Duncker Streett & Co's iShares Biotechnology ETF position peaked at $291K in Q4 2020.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Duncker Streett & Co's 13F filing for Q2 2026, filed 28 Jul 2026.